ArticleHepatology (Baltimore, Md.)2020

Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain-Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma.

Carmen Oi Ning Leung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.